Target intelligence / Profile preview

Periplakin (PPL)

Target
PPL
Molecular classification
Structural protein, Plakin family protein, Cornified envelope protein
01

Overview

Periplakin is a structural protein encoded by the PPL gene in humans, classified as a member of the plakin family[5][2][3]. It is predominantly expressed in keratinocytes and incorporated into the cornified envelope, contributing to the protective barrier function of the epidermis[1][3][5]. The protein contains distinct domains: its N-terminal region interacts with the plasma membrane, the rod domain facilitates complex formation with envoplakin (another plakin family protein), and its C-terminus interacts with intermediate filaments, anchoring desmosomes to the cornified envelope[2][3][1]. Periplakin plays a key role in tissue structural integrity and is implicated as an autoantigen in paraneoplastic pemphigus, an autoimmune blistering disease[3]. It has limited tissue distribution but is essential for epidermal barrier formation and cellular architecture. There are currently no therapeutic agents directed at periplakin.

Other names
190 kDa paraneoplastic pemphigus antigen195 kDa cornified envelope precursor proteinKIAA0568Periplakin
02

Mechanism of action

null

03

Biological functions

Structural integrity of the epidermisEpidermal differentiationCytoskeletal organizationLinks cornified envelope to desmosomes and intermediate filaments[1][3][5]
04

Disease associations

Paraneoplastic pemphigus (as an autoantigen)Skin barrier dysfunction (genetic deficiency or autoantibody-mediated)[3]
05

Biomarkers

Autoantibody detection (paraneoplastic pemphigus diagnosis; periplakin is one of the autoantigenic targets)[3]

Beyond the preview

Go deeper on Periplakin (PPL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Periplakin (PPL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call